what is ss31 peptide a small, mitochondria-targeting peptide - SS-31peptidebodybuilding SS-31 Unveiling the Power of SS-31 Peptide: A Mitochondria-Targeted Antioxidant for Cellular Health

SS-31peptidesupplement The quest for enhanced cellular function and the mitigation of age-related decline has led to significant interest in novel therapeutic agents2025年10月21日—SS-31(Elamipretide) is a mitochondria-targetedpeptidedesigned to improve energy production and reduce oxidative stress. Researchers have .... Among these, the SS-31 peptide, also known as Elamipretide, Bendavia, or MTP-131, has emerged as a focal point of scientific research.作者：H Zhao·2017·被引用次数：79—SS-31 is a novel mitochondrion-targeted antioxidant, which accumulates in the inner mitochondrial membrane, where the electron transport chain ... This mitochondria-targeting peptide is a small molecule designed to specifically interact with and improve the function of mitochondria, the powerhouses of our cells.作者：P List—SS-31 is a novel mitochondrial-target therapy peptidethat crosses the blood brain barrier (BBB) and targets the inner mitochondrial membrane (IMM). Its ability to scavenge reactive oxygen species (ROS) and support cellular energy production positions it as a promising treatment for multiple aging-related changes.

At its core, SS-31 is a novel mitochondrial-target therapy peptide. It is a small peptide with a specific amino acid sequence (D-Arg-dimethyl-Tyr-Lys-Phe-NH2) that allows it to readily cross cell membranes and accumulate within the mitochondria, particularly at the inner mitochondrial membrane (IMM). This targeted accumulation is crucial for its therapeutic effects. The Szeto-Schiller peptide SS31 is a mitochondria-penetrating peptide that partitions to the IMM, where it directly influences mitochondrial function. Research indicates that SS-31 targets mitochondria by selectively interacting with cardiolipin, a lipid essential for the structure and function of the IMM.

One of the primary mechanisms by which the SS-31 peptide exerts its benefits is through its potent antioxidant propertiesSS-31 (also known as Elamipretide®, Bendavia®, and .... As a mitochondria-targeting antioxidant, it plays a vital role in reducing mitochondrial reactive oxygen species production. This is particularly important because aged mitochondria often exhibit increased ROS generation, contributing to oxidative stress and cellular damage.The antioxidant peptide SS31 prevents oxidative stress ... By acting as a mitochondria-targeted antioxidant peptide, SS-31 can scavenge these harmful molecules, thereby protecting cellular components from oxidative damage. Studies have shown that SS31 is a mitochondria-targeted antioxidant peptide that can effectively reduce mitochondrial ROSSummit Series SS-31: What is it and what does it do?.

The impact of SS-31 extends to improving mitochondrial energy production, a process critical for overall cellular health and function作者：Y Zhu·2022·被引用次数：57—SS-31, a mitochondria-targeting antioxidant, has received significant research attention as it decreases mitochondrial reactive oxygen species production.. By enhancing the efficiency of the electron transport chain, this peptide can boost ATP production, the primary energy currency of the cell. This leads to a rejuvenation of cellular energetics, with studies demonstrating that SS-31 rapidly rejuvenates oxidative phosphorylation in aged skeletal muscle. This improvement in energy metabolism is fundamental to combating various age-related dysfunctions2025年9月10日—Explore howSS-31 targets mitochondriato boost ATP, reduce oxidative stress, and support recovery. Benefits, mechanisms, dosing, safety, ....

The therapeutic potential of SS-31 is being explored across a range of conditions and aging-related issues.Performance Medical Clinic - Education For instance, research has investigated its role in improving mitochondrial function in the context of kidney disease, with SS-31 peptide kidney studies showing beneficial effects. Furthermore, the peptide has demonstrated promise in addressing age-related cognitive decline and physiological changes. Its ability to cross the blood-brain barrier (BBB) allows it to exert its protective effects within the central nervous system.Elamipretide

Beyond its antioxidant and energy-boosting capabilities, SS-31 has shown potential in other areas. For example, SS31 treatment reduces Aβ production, suggesting a possible role in neurodegenerative diseases. It has also been explored for its benefits on cardiac mitochondrial dysfunction and its potential to improve osteogenic differentiation in aged bone. The Szeto–Schiller (SS) peptides represent a class of amphipathic tetrapeptides that are efficacious toward a wide array of mitochondrial disorders.

It is important to note that while research is ongoing, SS-31 is also being investigated as a medication used for the treatment of Barth syndrome, a rare genetic disorder affecting mitochondria. This highlights the broad therapeutic scope of this mitochondria-targeting peptide.

In summary, SS-31 peptide is a remarkable small, mitochondria-targeting peptide that offers a novel approach to enhancing cellular health and combating age-related decline. Its ability to target mitochondria, reduce oxidative stress, and improve energy production underscores its significance in the field of cellular therapeutics. As research continues to uncover its full potential, SS-31 stands as a testament to the power of targeted peptide therapies in supporting fundamental cellular processes and promoting overall well-being.